tiprankstipranks
InMed Pharmaceuticals (INM)
NASDAQ:INM

InMed Pharmaceuticals (INM) Cash flow

257 Followers

InMed Pharmaceuticals Cash Flow

INM's free cash flow for Q3 2024 was $-1.93M. For the 2024 fiscal year, INM's free cash flow was decreased by $8.18M and operating cash flow was $-1.93M. See a summary of the company’s cash flow.
Cash Flow
TTM
Jun 23Jun 22Jun 21Jun 16Jun 14
Operating Cash Flow
$ -6.61M$ -7.28M$ -15.58M$ -9.79M$ -386.07K$ -641.38K
Investing Cash Flow
$ -42.90K$ -661.80K$ -673.00K$ -1.73K$ -885.00$ -2.03K
Financing Cash Flow
$ 4.65M$ 10.68M$ 15.07M$ 10.85M$ 300.14K$ 646.44K
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
$ 32.79M$ 8.91M$ 6.18M$ 7.36M$ 41.92K$ 7.11K
Income Tax Paid Supplemental Data
------
Interest Paid Supplemental Data
------
Issuance Of Capital Stock
-$ 12.00M$ 17.15M$ 12.47M$ 304.68K$ 646.74K
Issuance Of Debt
--$ -290.83K---
Repayment Of Debt
--$ -290.83K---
Free Cash Flow
$ -6.78M$ -7.44M$ -15.62M$ -9.79M$ -386.96K$ -643.42K
Domestic Sales
------
Foreign Sales
------
Currency in USD

InMed Pharmaceuticals Cash Flow

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis